BDBM435154 US10584134, Example 2-1::US10584134, Example 2-15::US10584134, Example 2-16::US10584134, Example 2-17::US10584134, Example 2-18::US10584134, Example 2-19::US10584134, Example 2-20::US10584134, Example 2-21::US10584134, Example 2-22

SMILES COc1cnc(nc1NC(C)C)-c1ccccn1

InChI Key InChIKey=VGIYTWUCLMICKF-UHFFFAOYSA-N

Data  9 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 435154   

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  100nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  300nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  400nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  500nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  700nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  800nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  900nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent

LigandPNGBDBM435154(US10584134, Example 2-20 | US10584134, Example 2-2...)
Affinity DataEC50:  1.60E+3nMAssay Description:A test comparable with that previously described in the literature by Behrendt H. J. et al., Br. J. Pharmacol. 141, 2004, 737-745, is carried out. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent